News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
553,678 Results
Type
Article (43139)
Company Profile (84)
Press Release (510455)
Multimedia
Podcasts (88)
Webinars (10)
Section
Business (163972)
Career Advice (2119)
Deals (29159)
Drug Delivery (108)
Drug Development (70562)
Employer Resources (141)
FDA (13363)
Job Trends (12137)
News (284198)
Policy (30394)
Tag
2024 BioCapital Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (1)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (1)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (6)
2024 Biotech Beach Digital (2)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (1)
2024 Genetown Standard (7)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
2026 Genetown Standard (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2332)
Academic (1)
Accelerated approval (5)
Adcomms (22)
Allergies (74)
Alliances (49791)
ALS (70)
Alzheimer's disease (1287)
Antibody-drug conjugate (ADC) (116)
Approvals (13357)
Artificial intelligence (229)
Autoimmune disease (23)
Automation (13)
Bankruptcy (284)
Best Places to Work (9840)
BIOSECURE Act (17)
Biosimilars (90)
Biotechnology (59)
Bladder cancer (62)
Brain cancer (27)
Breast cancer (255)
Cancer (1959)
Cardiovascular disease (161)
Career advice (1789)
Career pathing (28)
CAR-T (130)
Cell therapy (376)
Cervical cancer (17)
Clinical research (56904)
Collaboration (826)
Compensation (462)
Complete response letters (20)
COVID-19 (2620)
CRISPR (39)
C-suite (176)
Cystic fibrosis (74)
Data (1863)
Decentralized trials (2)
Denatured (28)
Depression (40)
Diabetes (257)
Diagnostics (5088)
Digital health (15)
Diversity (5)
Diversity, equity & inclusion (43)
Drug discovery (112)
Drug pricing (105)
Drug shortages (30)
Duchenne muscular dystrophy (90)
Earnings (66589)
Editorial (41)
Employer branding (18)
Employer resources (125)
Events (76087)
Executive appointments (518)
FDA (14407)
Featured Employer (32)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (7)
Funding (624)
Gene editing (92)
Generative AI (25)
Gene therapy (287)
GLP-1 (750)
Government (4543)
Grass and pollen (5)
Guidances (46)
Healthcare (15374)
Huntington's disease (21)
IgA nephropathy (21)
Immunology and inflammation (112)
Indications (24)
Infectious disease (2768)
Inflammatory bowel disease (116)
Inflation Reduction Act (9)
Influenza (54)
Intellectual property (80)
Interviews (378)
IPO (12983)
IRA (46)
Job creations (2714)
Job search strategy (1506)
Kidney cancer (8)
Labor market (26)
Layoffs (378)
Leadership (17)
Legal (8145)
Liver cancer (59)
Lung cancer (278)
Lymphoma (133)
Machine learning (6)
Management (44)
Manufacturing (272)
MASH (62)
Medical device (9444)
Medtech (9448)
Mergers & acquisitions (16659)
Metabolic disorders (674)
Multiple sclerosis (65)
NASH (21)
Neurodegenerative disease (82)
Neuropsychiatric disorders (27)
Neuroscience (1757)
NextGen: Class of 2025 (5230)
Non-profit (3913)
Northern California (2087)
Now hiring (7)
Obesity (373)
Opinion (229)
Ovarian cancer (63)
Pain (72)
Pancreatic cancer (69)
Parkinson's disease (132)
Partnered (17)
Patents (204)
Patient recruitment (85)
Peanut (41)
People (39945)
Pharmaceutical (23)
Pharmacy benefit managers (12)
Phase I (17293)
Phase II (24672)
Phase III (19673)
Pipeline (1077)
Policy (145)
Postmarket research (2462)
Preclinical (7444)
Press Release (48)
Prostate cancer (101)
Psychedelics (31)
Radiopharmaceuticals (232)
Rare diseases (335)
Real estate (4048)
Recruiting (58)
Regulatory (19713)
Reports (32)
Research institute (2027)
Resumes & cover letters (320)
Rett syndrome (3)
RNA editing (3)
RSV (48)
Schizophrenia (71)
Series A (104)
Series B (62)
Service/supplier (6)
Sickle cell disease (50)
Southern California (1778)
Special edition (10)
Spinal muscular atrophy (145)
Sponsored (25)
Startups (2615)
State (2)
Stomach cancer (14)
Supply chain (61)
Tariffs (30)
The Weekly (58)
United States (18026)
Vaccines (740)
Venture capitalists (32)
Weight loss (267)
Women's health (25)
Worklife (15)
Date
Today (129)
Last 7 days (504)
Last 30 days (2082)
Last 365 days (27371)
2025 (8375)
2024 (29181)
2023 (32824)
2022 (42430)
2021 (45739)
2020 (44234)
2019 (38015)
2018 (28629)
2017 (27042)
2016 (26126)
2015 (29845)
2014 (24397)
2013 (20864)
2012 (21493)
2011 (21599)
2010 (20148)
Location
Africa (801)
Alabama (47)
Alaska (6)
Arizona (136)
Arkansas (9)
Asia (33538)
Australia (5846)
California (4686)
Canada (1582)
China (441)
Colorado (213)
Connecticut (224)
Delaware (115)
Europe (79920)
Florida (741)
Georgia (168)
Hawaii (1)
Idaho (37)
Illinois (404)
India (26)
Indiana (249)
Iowa (8)
Japan (141)
Kansas (79)
Kentucky (20)
Louisiana (10)
Maine (44)
Maryland (793)
Massachusetts (3512)
Michigan (169)
Minnesota (244)
Mississippi (1)
Missouri (61)
Montana (24)
Nebraska (15)
Nevada (50)
New Hampshire (37)
New Jersey (1467)
New Mexico (21)
New York (1371)
North Carolina (782)
North Dakota (5)
Northern California (2087)
Ohio (162)
Oklahoma (12)
Oregon (24)
Pennsylvania (1084)
Puerto Rico (6)
Rhode Island (22)
South America (1092)
South Carolina (17)
South Dakota (1)
Southern California (1778)
Tennessee (86)
Texas (666)
Utah (141)
Virginia (119)
Washington D.C. (50)
Washington State (415)
West Virginia (3)
Wisconsin (43)
553,678 Results for "eckert and ziegler ag".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Eckert & Ziegler Subsidiary Pentixapharm Receives Encouraging FDA Feedback to Initiate Phase III Trial with PentixaFor as Radiopharmaceutical Diagnostic in Primary Aldosteronism
Pentixapharm AG, a radiopharmaceutical development company wholly owned by Eckert & Ziegler SE, announced that it has received encouraging feedback from the U.S. FDA following a recent Type C meeting with the Agency to directly proceed into a pivotal phase III registration study with its radiopharmaceutical diagnostic Ga68-PentixaFor in Primary Aldosteronism.
June 25, 2024
·
3 min read
Press Releases
Telix and Eckert & Ziegler to Partner on Actinium-225 Production Technology
November 13, 2024
·
8 min read
BioMidwest
Eckert & Ziegler to Supply Nucleus RadioPharma with Therapeutic Radioisotopes Ac-225 and Lu-177
Eckert & Ziegler and Nucleus RadioPharma signed extensive supply agreements for major therapeutic radioisotopes.
January 31, 2024
·
3 min read
BioMidwest
Eckert & Ziegler and PharmaLogic Sign Reservation Agreement for Supply of Therapeutic Radioisotope Actinium-225
Eckert & Ziegler and PharmaLogic Holdings Corp. have signed a reservation agreement for the supply of the therapeutic radioisotope Actinium-225.
October 10, 2023
·
2 min read
BioMidwest
Eckert & Ziegler to Supply POINT Biopharma with Actinium-225
Eckert & Ziegler and a subsidiary of POINT Biopharma Global Inc. have signed an agreement on the supply of Actinium-225.
April 4, 2023
·
3 min read
RLS Radiopharmacies Partners with Eckert & Ziegler to Expand Production of Gallium-68-Based Radiopharmaceuticals
RLS Radiopharmacies, America’s only Joint Commission-accredited radiopharmacy network, has expanded its radiopharmaceutical contract development and manufacturing
April 4, 2024
·
3 min read
Press Releases
Maravai LifeSciences Appoints R. Andrew Eckert as Chairman of the Board of Directors
December 6, 2024
·
5 min read
BioMidwest
Eckert & Ziegler to Build Production Line for NorthStar Medical Radioisotopes’ Dedicated Actinium-225 Production Facility
NorthStar Medical Radioisotopes, LLC and Eckert & Ziegler Isotope Technologies Dresden announced an agreement for the purchase of hot cells and related equipment for NorthStar’s dedicated non-carrier-added actinium-225 production facility.
October 11, 2022
·
4 min read
Telix Expands Lutetium-177 Network with Eckert & Ziegler Clinical Supply Agreement
Telix Pharmaceuticals Limited announces a global clinical supply agreement with Berlin-based Eckert & Ziegler Strahlen- und Medizintechnik AG for highly pure no-carrier-added lutetium-177, a therapeutic isotope used in Telix’s portfolio of molecularly targeted radiation investigational products.
February 8, 2022
·
4 min read
Eckert & Ziegler to Build cGMP Facility for Radiopharmaceutical Services in Berlin
Eckert & Ziegler is proud to announce that it is expanding its production site in Berlin, Germany, with a new production facility for the contract manufacturing of radiopharmaceuticals.
April 14, 2021
·
3 min read
1 of 55,368
Next
